Triumph Capital Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45
Closed -$1.46K 1865
2025
Q4
$1.46K Buy
+45
New +$1.93K ﹤0.01% 1518
2023
Q3
Sell
-24,670
Closed -$232K 230
2023
Q2
$232K Buy
+24,670
New +$245K 0.11% 183

Other funds holding HIMS

Triumph Capital Management's HIMS Position: Q1 2026 in Review

Triumph Capital Management sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 45 shares — an estimated $1.46K sold.

Triumph Capital Management first reported a position in HIMS in Q2 2023 and held it in 2 quarters. The position peaked at $232K in Q2 2023. 436 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Triumph Capital Management reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
  • Triumph Capital Management sold 45 Hims & Hers Health shares in Q1 2026, an estimated $1.46K.
  • Triumph Capital Management first reported a position in Hims & Hers Health in Q2 2023 and held it in 2 quarters.
  • Triumph Capital Management's Hims & Hers Health position peaked at $232K in Q2 2023.
  • 436 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Triumph Capital Management's 13F filing for Q1 2026, filed 13 May 2026.